首页>
外国专利>
DEVELOPMENT OF BIOMARKER FOR KETOGENIC DIET-BASED CANCER TREATMENT
DEVELOPMENT OF BIOMARKER FOR KETOGENIC DIET-BASED CANCER TREATMENT
展开▼
机译:基于生酮饮食的癌症生物标记物的开发
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method for selecting a cancer patient for whom a ketogenic diet therapy would be effective and a method for predicting efficacy of a ketogenic diet therapy in a cancer patient are provided. A method is characterized by obtaining a result of analysis of at least one pre-intake candidate substance selected from the group consisting of acylcarnitine(12:0), acylcarnitine(12:1)-2, acylcarnitine(12:1)-3, acylcarnitine(14:1)-1, acylcarnitine(14:2)-1, acylcarnitine(14:2)-2, acylcarnitine(14:3)-2, acylcarnitine(16:1), acylcarnitine(16:2), anandamide, heptadecenoic acid, hypotaurine, linoleylethanolamide, palmitoleic acid, palmitoylcarnitine, phytosphingosine, quinic acid, uric acid, alanine, citrulline, tryptophan and lysine in a serum derived from a cancer patient prior to intake of a ketogenic diet, and using the result of analysis as an indicator.
展开▼